Andrew J. Schwab
Director, 10% Owner · Skye Bioscience, Inc.
- 2024
- Sep 24, 2026
- 14
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew J. Schwab files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- 5AM Partners VI, LLC - $4.86M in CAMP purchases and sales in the last 12 months
- 5AM Partners VII, LLC - $445K in SKYE purchases and sales in the last 12 months
- Kelly Gold - $50K in CAMP purchases and sales in the last 12 months
- Richard A. Young - $27K in CAMP purchases and sales in the last 12 months
- Yuri Maricich - $11K in CAMP purchases and sales in the last 12 months
- Josh Mandel-Brehm - $11K in CAMP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew J. Schwab?
Andrew J. Schwab is a corporate insider, tracked as Director, 10% Owner of Skye Bioscience, Inc. (SKYE). InsiderAlpha holds 14 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew J. Schwab submitted recently?
7 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Andrew J. Schwab been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10.00M) and 24 open-market sales ($3.74M) across all tracked filings.
